Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study.  Wilson J, Mills KL, Sunderland M, Freeman TP, Keaveny M, Haasnoot K, Teesson M, Haber PS, Marel C.  Int J…

Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff.  Wu, LT., Mannelli, P., John, W.S. et al. Subst Abuse Treat Prev Policy 18, 55 (2023). doi.org/10.1186/s13011-023-00563-w https://s…

Typology of laws restricting access to methadone treatment in the United States: A latent class analysis.  Conway A, Krawczyk N, McGaffey F, Doyle S, Baaklini V, Marshall AD, Treloar C, Davis CS, Colledge-Frisby S, Grebely J, Cerdá M.  Int…

First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada.  Bouck Z, Tricco AC, Rosella LC, Banack HR, Fox MP, Platt…

Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled t…

Schottland. MAT Service Standards- Leaflet for people in treatment (June 2023) (sdf – Scottish Drugs Forum, Schottland, 2023)  https://www.matstandards.co.uk/s/MAT-Leaflet-People-Using-Services-SDF-June-2023V1.pdf